Physician profile
Karine Yu
NPI 1558774752
$1,213.54
in general payments reported to CMS, 2019-2025
15 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $97.85 · 2021: $243 · 2022: $209 · 2023: $189 · 2024: $150 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $367.58 | 2022-2025 | Botox, Ubrelvy |
| Allergan, INC. | $353.95 | 2019-2022 | |
| Bioventus LLC | $130.51 | 2019-2022 | |
| Stryker Corporation | $70.83 | 2022 | |
| Convatec INC. | $39.67 | 2020-2023 | |
| Pacira Therapeutics, INC. | $39.03 | 2021 | |
| Endo USA, INC. | $37.93 | 2025 | Xiaflex |
| Polynovo North America LLC | $32.83 | 2025 | Novosorb Btm |
| Kci USA, INC. | $32.15 | 2019-2021 | |
| Fidia Pharma USA INC. | $28.11 | 2022-2023 | Hyalgan |
| Averitas Pharma INC. | $18.72 | 2024 | Qutenza |
| Axogen | $18.11 | 2019 | |
| Smith+Nephew, INC. | $16.46 | 2023 | Pico 7 |
| Depuy Synthes Sales INC. | $14.14 | 2024 | Monovisc |
| Endo Pharmaceuticals INC. | $13.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karine Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.